Germany on Thursday rejected a U.S. proposal to waive patent protection for COVID-19 vaccines, saying the greatest constraints were not intellectual property protection but vaccines' production capacity and their quality.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3